CX Partners
Finance
SIS IPO subscribed seven times; Cochin Shipyard issue covered thrice on day 2
Security and Intelligence Services (India) Ltd saw a strong investor turnout for its initial public offering with the issue covered ......
Finance
CX Partners rewards SIS promoters for strong IPO show
Private equity firm CX Partners, which is making a partial exit in Security & Intelligence Services (India) Ltd's ongoing public ......
Infrastructure
Cochin Shipyard IPO subscribed 92%; SIS issue covered nearly twice
The initial public offering of state-run Cochin Shipyard Ltd was almost fully covered while that of CX Partners-backed Security and ......
General
CX Partners-backed SIS IPO crosses one-third mark on day one
The initial public offering (IPO) of Security and Intelligence Services (India) Ltd, which is backed by private equity firm CX ......
Infrastructure
How much return will CX Partners churn out from SIS IPO?
Homegrown private equity firm CX Partners will likely walk away with bountiful returns by partially exiting its four-year-old investment in ......
General
CX Partners-backed security service provider SIS eyes $925 mn valuation in IPO
CX Partners-backed Security and Intelligence Services (India) Ltd (SIS) is seeking a valuation of as much as Rs 5,960 crore ......
Healthcare
TPG in talks with European firm to sell Sutures ahead of IPO
Private equity firm TPG is considering a sale of Sutures India Pvt. Ltd to a European company, even as a ......
Healthcare
CX Partners clocks high returns from healthcare portfolio firm
Barely a fortnight after exiting Natco Pharma Ltd with stellar returns, homegrown private equity firm CX Partners has made a ......
People
Former Star India exec joining infrastructure finance firm as legal head
Pulak Bagchi, former senior vice president (legal and regulatory) of Star India Pvt. Ltd, is joining a Kolkata-based infrastructure finance ......
Healthcare
CX Partners spinning a multi-bagger from pharma firm
Homegrown private equity firm CX Partners is harvesting a rich return from a four-year-old investment in an Indian drugmaker that ......